cTnI - 2
Art:
715595-00R
Rev. Date: 23-May-12
Metrological Traceability
The i-STAT System test for cardiac troponin-I (cTnI) measures cardiac troponin-I amount-of-substance
concentration in plasma or the plasma fraction of whole blood (dimension ng mL
-1
) for
in vitro
diagnostic
use. Cardiac troponin-I values assigned to i-STAT’s controls and calibration verification materials are
traceable to i-STAT’s working calibrator prepared from human cardiac troponin-ITC complex (Hy-Test
Ltd., Turku, Finland, catalogue #8T62). i-STAT System controls and calibration verification materials are
validated for use only with the i-STAT System and assigned values may not be commutable with other
methods. Further information regarding metrological traceability is available from Abbott Point of Care
Inc..
Reportable Range
The i-STAT cTnI test will report 0.00 to 50.00 ng/mL (µg/L). Samples above the reportable range will yield
“>50.00 ng/mL” on the analyzer display screen. However, the performance characteristics of the i-STAT
cTnI measurement have not been established for cTnI values above 35.00 ng/mL (µg/L).
Reference Range
Whole blood and plasma samples from 162 apparently healthy donors were assayed in duplicate using
three different lots of i-STAT cTnI cartridges. The 0 to 97.5% range of results spanned 0.00 ng/mL (µg/L)
to 0.03 ng/mL (µg/L). The 0 to 99% range of results spanned 0.00 ng/mL (µg/L) to 0.08 ng/mL (µg/L).
Note: Each facility should establish its own reference range using the i-STAT cTnI assay.
Clinical Significance
Biochemical cardiac markers, including cTnI, are useful for both the diagnosis of myocardial infarction and
the risk stratification that can help guide the choice of therapeutic options.
For optimal diagnostic usefulness, a cardiac marker should be specific for cardiac tissue, should be rapidly
released into the bloodstream with a direct proportional relationship between the extent of myocardial injury
and the measured level of the marker, and should persist in blood for a sufficient length of time to provide a
convenient diagnostic time window.
1
The cardiac-specific troponins, troponin I (cTnI) and troponin T (cTnT)
are considered the biochemical markers of choice in the evaluation of acute coronary syndromes (ACS)
including ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina.
2,3
Elevated levels of cardiac-specific troponins convey prognostic information beyond that supplied by the
patients clinical signs and symptoms, the ECG at presentation, and the pre-discharge exercise test.
1
Antman
et al. reported that patients with elevated levels of cTnI had a statistically significant increase in mortality
(p< 0.001).
4
Other studies have shown increases in other non-fatal cardiac events such as non-fatal MI,
congestive heart failure, and urgent revascularization with increasing levels of cTnI.
5,6,7
The ability for cTnI to be measured at low concentrations allows therapeutic intervention to be considered at
any elevation above the normal range. Patients that present with no ST-elevation on their ECG but who have
even slight elevation in cTnI or cTnT may receive a greater treatment benefit from certain drugs such as GP
IIb/IIIa inhibitors or low molecular weight heparin.
8,9,10
A Global Task Force with joint leadership from the European Society of Cardiology (ESC), the American
College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and the World Heart
Federation (WHF) refined past criteria of myocardial infarction with a universal definition of myocardial
infarction that supports the use of cTnI as a preferred biomarker for myocardial injury. The universal
definition of MI according to this task force is defined as a typical rise and gradual fall of cardiac biomarkers
(preferably troponin) with at least one value above the 99th percentile of the upper reference limit (URL)
together with evidence of myocardial ischemia with at least one of the following: ischemic symptoms,
pathological Q waves on electrocardiogram (ECG), ischemic ECG changes, or imaging evidence of new
loss of viable myocardium or new regional wall motion abnormality.
2
An elevated troponin value alone is
not sufficient to diagnose a myocardial infarction. Rather, the patient’s clinical presentation (history, physical
Summary of Contents for i-STAT 1
Page 1: ...i STAT 1 System Manual Rev Date 20 Jan 12 Art 714336 00L ...
Page 18: ...1 8 Art 714363 00U Rev Date 02 Aug 12 ...
Page 44: ......
Page 90: ......
Page 106: ...9 12 Art 714371 00E Rev Date 06 Aug 12 ...
Page 162: ......
Page 166: ...Art 730292 00A Rev Date 20 Feb 12 4 ...
Page 176: ...10 10 Art 714372 00L Rev Date 30 Jul 12 ...
Page 182: ...11 6 Art 714373 00F Rev Date 17 Jan 11 ...
Page 184: ...12 2 Art 714374 00J Rev Date 25 Aug 11 ...
Page 185: ...Art 714374 00J Rev Date 25 Aug 11 12 3 ...
Page 186: ...12 4 Art 714374 00J Rev Date 25 Aug 11 ...
Page 187: ...Art 714374 00J Rev Date 25 Aug 11 12 5 ...
Page 192: ......
Page 194: ......
Page 214: ...14 20 Art 714376 00M Rev Date 31 Jan 12 ...
Page 216: ...14 22 Art 714376 00M Rev Date 31 Jan 12 ...
Page 218: ...14 24 Art 714376 00M Rev Date 31 Jan 12 ...
Page 220: ...14 26 Art 714376 00M Rev Date 31 Jan 12 ...
Page 222: ...14 28 Art 714376 00M Rev Date 31 Jan 12 ...
Page 224: ...14 30 Art 714376 00M Rev Date 31 Jan 12 ...
Page 226: ......
Page 236: ......
Page 252: ...17 4 Art 714379 00F Rev Date 18 Jul 12 ...
Page 254: ......
Page 294: ...Art 725768 00E Rev Date 04 Jan 12 20 ...
Page 336: ...22 2 Art 714384 00D Rev Date 07 18 06 ...
Page 342: ...22 8 Art 714384 00D Rev Date 07 18 06 ...
Page 348: ...22 14 Art 714384 00D Rev Date 07 18 06 ...
Page 352: ...22 18 Art 714384 00D Rev Date 07 18 06 ...
Page 364: ...22 30 Art 714384 00D Rev Date 07 18 06 ...
Page 384: ...22 50 Art 714384 00D Rev Date 07 18 06 ...
Page 404: ...22 70 Art 714384 00D Rev Date 07 18 06 ...
Page 488: ...Kaolin ACT 4 Art 715878 00M Rev Date 31 Jan 12 ...
Page 536: ......
Page 556: ...Art 714261 00E Rev Date 10 Jan 11 8 ...
Page 560: ...Art 716240 00D Rev Date 03 Mar 10 4 ...
Page 572: ...Art 715617 00D Rev Date 06 11 08 ...
Page 578: ...Art 714547 00F Rev Date 06 11 08 ...
Page 590: ...Art 720735 00B Rev Date 06 11 08 ...
Page 592: ...Art 721106 00B Rev Date 06 11 08 ...
Page 598: ...Art 722831 00A Rev Date 19 Feb 09 ...
Page 610: ...Art 720654 00B Rev Date 06 11 08 ...
Page 614: ...Art 721317 00D Rev Date 13 Aug 12 4 ...
Page 616: ...Art 725703 00A Rev Date 08 Mar 10 2 ...
Page 618: ...Art 721296 00A Rev Date 07 16 08 ...
Page 620: ...REV DATE 16 Oct 12 ART 714446 00L ...
Page 627: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 6 REV DATE 16 Oct 12 ART 714446 00L ...
Page 628: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 7 REV DATE 16 Oct 12 ART 714446 00L ...
Page 629: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 8 REV DATE 16 Oct 12 ART 714446 00L ...
Page 630: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 9 REV DATE 16 Oct 12 ART 714446 00L ...
Page 658: ......